Colorectal cancer screening sector is worth ~ $38 billion across US, Europe, China, Japan and Australia
When Governments are funding huge costs of dealing with resulting cancers vs the cheap as chips option of screening and fixing at early onset - it's a no-brainer. Governments save big amounts of cash and lives are saved.
Of course there are risks such as competitors, testing failure, red tape etc but all things considered in my opinion I think it's a fantastic risk to reward ratio.
Ann: Appendix 4D and Half Yearly Report and Accounts, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $5.166K | 51.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 164195 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.43pm 18/10/2024 (20 minute delay) ? |
| RHY (ASX) Chart |